* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Immunology 5
Survey
Document related concepts
Immune system wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Duffy antigen system wikipedia , lookup
DNA vaccination wikipedia , lookup
Innate immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Molecular mimicry wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Adaptive immune system wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
X-linked severe combined immunodeficiency wikipedia , lookup
Transcript
Immunology 5 – B lymphocytes Why are B and T lymphocytes relevant? Their absence results in an inability to fight infections. B and T lymphocytes are said to operate during adaptive immune responses. But what are adaptive immune responses? Responses tailored towards fighting a particular pathogen by means of the specificity between the B cell receptor or the T cell receptor towards the antigens displayed by that pathogen. Adaptive immunity is evolutionarily more recent than innate immunity. Innate immunity which is activated within minutes of encountering a given antigen serves to not only buy time while the adaptive system is galvanized into action but it also forms an important part in actually secreting certain soluble mediators which can increase lymphocyte production and by displaying the antigens on MHC Class 2 receptors by particular professional antigen presenting cells. All of these responses result in the activation of the adaptive immune system which is responsible and capable of halting most infections and killing the pathogen involved by a number of ways. The b and the t lymphocytes, in essence, form the effector arms of adaptive immunity. Humoural immunity is largely determined by B cells. They are responsible for the production of antibodies; the topics for discussion in the lecture prior to this, and the cell mediated immunity is handled by the T lymphocytes. B lymphocytes, in summary, are white blood cells responsible for the production of antibodies and some of them also form memory cells following the initial exposure of a pathogen, which allows for a quicker, faster and more effective response on second encounter with the particular pathogen. B cells are derived from haematopoietic stem cells in the bone marrow. They, unlike the t cells, also develop and mature within the bone marrow. Following this, they migrate into the circulation, blood and lymph circulation, and can act and carry out their respective functions in this manner. B cell generation and maturation actually occurs in the bone marrow in the absence of any antigen. But antibody production is a strictly antigen-mediated process, B cells must be activated in the presence of an antigen before they can produce antibodies, which form the effector arms of adaptive immunity along with the T cells. The latter part occurs in the lymphoid organs. In the bone marrow, in the absence of antigen, a pro B cell becomes a pre B cell which becomes an immature B cell which becomes a mature B cell. The B cell specificity lies in the B cell receptor, which includes a surface immunoglobulin molecule, and we find that each BCR is specific for interaction with only a particular antigen. Many identical B cell receptors are present on the surface of a given B cell conferring specificity towards a particular antigen. BCRs have particular antigen binding region, which encapsulates the immense diversity seen in these receptors. The structure of the b cell receptor The B cell receptor is a transmembrane complex with certain sections of the protein projecting out towards the extracellular environment and some regions remaining inside, on the cytosolic surface of the cell. It is composed of mLgG along with di-sulphate linked heterodimers known as lg alpha and beta. The latter components are necessary for the efficient functioning of the BCR because they have cytoplasmic tails long enough for the signal transduction necessary compensating for the short cytoplasmic tail of the main immunoglobulin molecule. Note that the latter molecules are also part of the immunoglobulin supergene family and therefore have immunoglobulin-like folds and domains. Immunoglobulin Genes and the process of re-arrangement As mentioned before, the immunoglobulins have two chains, the light and the heavy chains. Each chain has a variable and constant region. Instead of being encoded by a single contiguous DNA sequence, the immunoglobulin polypeptide chains are encoded by a set of gene segments or more accurately, sets of gene segments. These gene segments can be selected and re-arranged and joined together in various ways during B cell development and it is this process of recombination which is responsible for what is known as the generation of diversity in the B cell receptors. As we will see shortly in the next lecture, the diversity of the T cell receptor is developed in a similar way. It should also be noted that this process of gene segment re-arrangement and joining seems to be entirely specific to the immune system. These gene segments include Joining and Diversity genes in addition to the Variable and Constant genes. J, D and V will eventually unite to form one functional gene encoding the variable segment of the chain. Each given set of segments is variety of genes which encode for that particular piece of gene. To understand this better, one can imagine there being for example a number of leader genes, a number of joining genes, a number of diversity genes and so on. One can immediately see the simply logic of arranging genes in this manner. We can generate an enormous, almost unlimited diverse array of different functional genes encoding for the variable regions which allows the human immune system as a whole to have a vast repertoire of B and T cells which specificities for almost every antigen possible. During the development of the B cells, the gene segments are brought closer together, rearranged and then joined in a particular order. The process of re-arrangement is known as somatic recombination and occurs in the complete absence of antigen to generate that aforementioned repertoire. Once the complete light and heavy chain genes have assembled, they can be transcribed and translated to assemble the B cell receptor, the surface immunoglobulin. Alternatively, the molecule can be separated from the B cell and secreted into the plasma as soluble antibody. Note that the process of gene re-arrangement and subsequent joining in new configurations is exactly the same for immunoglobulins destined for the surface of the B cell or destined to be released into the fluid surrounding cells, etc. After the initial gene re-arrangements have taken place, the entire gene is transcribed including the exons and the introns. The introns are then spliced by means of spliceosome and the resulting processed mRNA can be translated into protein. The leader peptide sequence is then removed by proteolytic enzymes. This brings the VJ segment or VDJ segment (in the case of heavy chains close to particular Constant chain mRNA) The V region of light chains is composed of V and J segments but heavy chains have V, D and J segments. In order for a complete V region to be transcribed the V and the J regions, for a given light chain, must be cut out of the germline DNA by means of certain enzymes, discussed later, and then rejoined in a particular unique configuration, certain enzymes are once again, involved. For example one J segment from a range of J segments is selected and combined with one V segment from a range of V segments. For the heavy chains, a similar selection occurs for the V, D and J segments resulting the in the completion of a complete Variable Heavy gene. The complex of enzymes involved in the somatic recombination process is known as VDJ recombinase. The enzymes are responsible for the cleavage and rejoining of the DNA involved in re-arrangement. Two of these enzymes, RAG1 and RAG2 are responsible for the first cleavage step. These enzymes are only found in lymphocytes. Human light chain synthesis There are two types of light chains in antibodies which can be found in ALL the five classes of antibodies, the kappa and the lambda chains. The gene locus for the kappa chain is contained on a particular locus of chromosome 2. In the germline of humans, there are approximately 30 different V kappa genes found in the kappa locus of chromosome 2. We find that each V kappa genes encodes from 1 to 95 amino acids stemming from the N region of the polypeptide. Downstream of the V kappa genes, we can find the J kappa genes. There are, of course, a number of J kappa genes but EACH one of them encodes for amino acids 96-108 of the kappa variable region. After a long intron section, the locus ends in one C kappa exon, which is responsible for encoding the constant region of the Kappa light chain. In order to synthesize a kappa light chain, a cell early in the B lymphocyte lineage selects a particular V kappa exon from a selection of V kappa exons and after a process of DNA re-arrangement catalyzed by VDJ recombinase, joins it to a particular J segment from a selectrion of J segments. The intervening DNA segment is looped out and removed, destined for ultimate degradation. From this re-arranged DNA, a primary RNA transcript is made. This primary RNA transcript then undergoes splicing in order to remove the intronal sections between the coding parts of the mRNA. This results in the particular V,J and C exons being brought together as one continuous linear section of nucleic acid. This RNA is now ready for translation in the cytoplasm. The process is similar to the lambda chains except that lambda chain loci are found on chromosome 22 in humans and there are about 30 variable lambda genes as well as four joining lambda genes, with each particular J segment being associated with a different constant lambda section. One can, therefore, infer that there are in fact four different classes of the lambda light chain in humans, depending on the variety conferred by the four different constant chains. Human heavy chain synthesis In the human genome, there are approximately 50 variable, 25 diversity, and six joining segments all involved in the encoding of the variable region of the heavy chains. In other words, there is an inclusion of another segment as compared to light chains, the diversity segment, which has been to shown to code for third hypervariable region or the complementarity determining region. The mechanism for heavy chain synthesis, otherwise, is quite similar to light chain synthesis. First the D and J segments are joined. Then the V segments joins to the completed DJ segments. The C region exons are brought closer together to VDJ segments by means of the RNA splicing introns between the respective exons. Note the abundance of different kinds of constant chains in the DNA. This is the basis for the five different antibody classes. The DNA can be re-arranged so that the complete VDJ segment can associate with different constant region by means of isotope switching or class switching. The different Ch receptors are responsible for different effector functions. This has been discussed in detail in the last section. Now that we have discussed the various processes involved in light and heavy chain synthesis, let us look quickly over the various ways in which diversity is generated as a whole in this process and related processes. 1. V, D and J segments are present in multiple different copies in the germline DNA. This is referred to, not surprisingly, as germline diversity. 2. VJ and VDJ segments can recombine in different ways and in multiple combinations. Due to the presence of multiple copies of the individual segments and the number of ways in which they can associate, we have a vast number of different combinations which can result. This is known as combinatorial diversity. 3. The formation of the junction between the V and the DJ segment involved DNA cleavage followed by the addition and subtraction of nucleotide to create a viable joint. As a result, different coding sequences can be created at the joint regions in different antibodies leading, once again, to much greater diversity. This is done through the random addition of nucleotides; the enzymes is responsible is terminal deoxynucleotidyl transferase or more simply, TdT. 4. Multiple combinations can occur between the light and heavy chains. This allows for a number of various combinations and as a result, we have a number of different antibody specificities. 5. Somatic hypermutation after encounter with the antigen can also function as an additional technique to generate an even better fit to the antigen and allowing for an increased affinity of the antigen to the antibody. The diagram demonstrates a protypical gene which encodes for a given membrane protein. This is important because of its obvious value in the synthesis of the B cell receptor, which does not consist only of the immunoglobulin, but also two other components, known as lg alpha and beta which exist in conjunction with the main immunoglobulin. They have longer cytoplasmic tails for efficient signalling, compensating for the relatively short cytoplasmic tail of the main surface immunoglobulin; not useful for signal transduction. Note also the synthesis of a transmembrane region composed largely of hydrophobic amino acids, which helps to hold the transmembrane protein in place, as a result of hydrophobic interactions with the components of the lipid bilayer. Adaptive immune responses are characterized by their specificity, diversity and memory. The basis of the adaptive immune response is clonal selection. If we review at this point, we find that the stem cells present in the bone marrow are subject to the generation of diversity, the VDJ recombinase enzymes are responsible for the formation and re-arrangement of the B cell DNA. The primary RNA transcript is synthesized and we find that VD, J and C segments can be effectively unified by splicing out of the introns in between the coding sections. This results in the formation of one complete, uninterrupted polypeptide chain, this is synthesized and then the process also happens for the light chains. (In actual fact, the heavy chain is synthesized first in the presence of a surrogate light chain and then the light chain is produced). At the end of this process, we have a B cell which is specific to a particular antigen, but it is still termed as an immature B lymphocyte. The last point of maturation is where the self-reactive B lymphocytes are destroyed. This is ultimately one of the trade-offs of such an incredibly diversity-generating process; there is absolutely no way of ensuring that some B cells will be produced which are reactive against the cells of the body. If these cells are not eliminated, then the immune response will be misdirected against the cells of the body, and then we’d be in trouble. Nevertheless, this process of elimination of self-reactive B lymphocytes is not fully perfect, as is demonstrated by the continued existence of autoimmunity. Clonal selection occurs when at this point, the mature B lymphocytes in the blood and the lymph encounter an antigen with a number of epitopes. Chances are that a number of B lymphocytes will each recognize a particular epitope of the antigen. This binding of the antigen to the BCR can bring about activation of the B cell which will then proliferate, produce clones and differentiate into plasma cells, tasked with producing large amounts of soluble antibody specific to that particular epitope, and memory cells which remain in the blood for a quicker response on a repeated exposure to that particular antigen. It should be noted, however, that B cells cannot be activated by exposure to antigen alone. They MUST be provided co-stimulation by either T helper cells or by certain microbial constituents or specialized accessory cells. The use of the T helper cells is what is known as Thymus dependent activation of B cells. This occurs for all the antibody classes and results in the production of memory. This occurs when the BCR binds to its complementary antigen. The receptor antigen complex is internalized, and enclosed within an endocytic vesicle where it fuses with a lysosome. The antigen is degraded into peptides, assembled along with MHC Class 2 molecules and displayed on the surface of the B cell. The T cells are now able to recognize this bound peptide antigen if they have the specific T receptor for the job and they secrete certain cytokines which bind to certain receptors on the B cells as a result of which the B cell enters the cell cycle, proliferates, produces a clone of identical B cells with the identical receptors, differentiates into memory cells and plasma cells. Hey presto, we gat a-bodies! However, there is also a means of Thymus independent activation by means of costimulation being provided by the microbial constituents or other specialized accessory cells. This latter form only encompasses lg M and does not result in the development of immunological memory. In Di george syndrome, individuals lack a thymus and T cells but they are still capable of producing antibody by this pathway. B cell proliferation is under the control of specific cytokines but under the influence of certain cytokines, class switching is said to occur. Final note on Immunological memory. The clonally expanded B and T cells produce as a result of the first encounter with the antigen diffentiate partly into memory cells, which also turn over in fact. These memory cells can effectively eliminate the pathogen on subsequent re-entry and this is what allows for a heightened, quicker and more effective response to the pathogen. This phenomenon allows for life-long immunity to certain pathogens, the memory cells can always protect the individual. Note the lg G is involved more actively in the secondary response whereas lgM predominates in primary response. Note also that antibody affinity increases with the duration of an infection and also with repeated infections. Read polyclonal and monoclonal antibodies from the books or lecture notes. Important factors to note are the hybridoma method for the production of monoclonal antibodies and their immense utility in diagnosis, treatment, etc.